Nephros (NEPH) Operating Margin Growth (3y) (2013 - 2026)
Nephros (NEPH) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.50 Bn | 128.29 Bn | 1.96 Bn | 722.00 |
| 2 | Becton Dickinson | 52.18 Bn | 51.32 Bn | 2.32 Bn | 205.00 |
| 3 | Alcon | 35.52 Bn | 34.16 Bn | 1.68 Bn | -2,360.00 |
| 4 | Resmed | 33.56 Bn | 32.09 Bn | 861.22 Mn | 612.00 |
| 5 | Medline | 28.58 Bn | 25.90 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 24.94 Bn | 24.51 Bn | 329.20 Mn | -368.00 |
| 7 | Solventum | 15.32 Bn | 14.91 Bn | 1.29 Bn | -1,189.00 |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn | -1,384.00 |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 799.00 |
| 10 | Nephros | 46.36 Mn | 41.66 Mn | 4.03 Mn | 3,243.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,243.00 |
| Mar 31, 2026 | 1,014.00 |
| Dec 31, 2025 | 2,747.00 |
| Sep 30, 2025 | 5,977.00 |
| Jun 30, 2025 | 3,417.00 |
| Mar 31, 2025 | 8,326.00 |
| Dec 31, 2024 | 3,477.00 |
| Sep 30, 2024 | 3,696.00 |
| Jun 30, 2024 | 3,955.00 |
| Mar 31, 2024 | 3,153.00 |
| Dec 31, 2023 | 1,086.00 |
| Sep 30, 2023 | 3,852.00 |
| Jun 30, 2023 | 8,906.00 |
| Mar 31, 2023 | 3,229.00 |
| Dec 31, 2022 | -1,789.00 |
| Sep 30, 2022 | -3,072.00 |
| Jun 30, 2022 | 903.00 |
| Mar 31, 2022 | 189.00 |
| Dec 31, 2021 | 1,865.00 |
| Sep 30, 2021 | -147.00 |